ADVERTISEMENT

COVID-19: neuropsychiatric sequelae may persist for 2 years

Miriam Davis, PhD   |   Clinical Summary   |   01 September 2022
ADVERTISEMENT

Takeaway

  • A new study of nearly 1.3 million COVID-19 cases finds different risk trajectories for neuropsychiatric sequelae: excess mood and anxiety disorder risks end after 2 months post-COVID-19 diagnosis, whereas excess risks for cognitive deficit ("brain fog"), dementia, psychotic disorders, and epilepsy or seizures remain at the end of 2-year...

          

Topic Challenges

left
right